Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

Filter Results:

Show Only Available Presentations

  • +

    P11 - Immuno-biology and Novel Immunotherapeutics (Phase I and Translational) - Clinical Trials in Progress

    • Type: Posters
    • Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
    • Presentations: 3
    • Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
    • +

      P11.01 - Phase I Trial of in Situ Vaccination With Autologous CCL21-Modified Dendritic Cells (CCL21-DC) Combined With Pembrolizumab for Advanced NSCLC

      00:00 - 00:00  |  Author(s): Aaron E Lisberg

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P47 - Novel Therapeutics and Targeted Therapies - Clinical Trial in Progress

    • Type: Posters
    • Track: Novel Therapeutics and Targeted Therapies
    • Presentations: 18
    • Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
    • +

      P47.05 - A Phase 2 Study of Datopotamab Deruxtecan (Dato-DXd) in Advanced NSCLC With Actionable Genomic Alterations (TROPION-Lung05)

      00:00 - 00:00  |  Presenter: Melissa L Johnson

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MA03 - Biomarkers for Immunotherapy: Are All Relevant?

    • Type: Mini Oral
    • Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
    • Presentations: 8
    • Coordinates: 9/08/2021, 10:45 - 11:45, Program Auditorium
    • +

      MA03.02 - TROPION-PanTumor01: Updated Results From the NSCLC Cohort of the Phase 1 Study of Datopotamab Deruxtecan in Solid Tumors

      10:50 - 10:55  |  Presenter: Edward B Garon

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.